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A B S T R A C T   
Sustainable nutrition, equaling earth health, involves a personalized approach designed in terms of precision and 
avoidance of still cogent but unjustified dogmas, equaling public health. For instance, current dietary recom-
mendations continue to dwell on the need to limit as much as possible the intake of saturated fatty acids (SFA), 
notwithstanding the mounting evidence that the effects of food on health cannot be predicted from the content of 
single nutrients without considering the overall macronutrient composition and the role of the food matrix. The 
traditional recommendation to restrict SFA ignores that their effects on health depend on the interaction between 
naturally occurring food components and those introduced by food processing. It is warranted to modify the still 
widely promoted dietary guidelines based upon such single nutrients as SFA and instead personalize dietary 
habits on the basis of the whole pattern of the food matrix. Accordingly, the double edge of malnutrition, that 
involves deficiency as well as excess and materializes in many individuals throughout their life course, might be 
tackled by implementing sustainability, with the additional effect of overcoming global inequalities. Within this 
context SFA may regain their position of tasty and cheap sources of energy to be adapted to each individual 
lifestyle.   
1. Introduction 
In the difficult times amidst the SARS-CoV-2 pandemic, the whole 
world has become more conscious of the importance of primary and 
secondary prevention. COVID-19 is already having a triple hit on health, 
education and income, but at the same time this scourge offers 
tremendous opportunities for reaching the 2030 Agenda and the Sus-
tainable Development Goals. In the frame of the pandemic, the planet 
gave us the strongest warning that the mankind must change in order to 
prevent the ongoing worldwide degradation of the ecosystem. At the 
same time, it has become increasingly clear that COVID-19 has a 
disproportionate impact on those communities that were already facing 
disadvantages and discrimination. The impact of the pandemic has been 
particularly detrimental in people living in areas of high deprivation, 
and in those with chronic conditions such as diabetes, hypertension and 
obesity. Inequalities are putting at risk of malnutrition not only children 
in developing and transition countries but also minorities in high income 
countries, further contributing to social inequalities in healthcare, dis-
ease prevention and treatment that impinge upon this and the next 
generations [1]. In this context, disease prevention may indeed be the 
key for mitigating both the COVID-19 syndemic and the burden asso-
ciated with the issues of sustainable food and nutrition. Food is once 
more at the core of many of the world’s health, environmental, social 
and economic challenges, as witnessed by the 2020 award of the Nobel 
Peace Prize to the World Food Programme for the efforts towards bet-
tering not only food availability but also security. The issues – from earth 
health to public health – are complex and cannot be solved in isolation 
during the current syndemic that, whether cause and/or effect, is tightly 
connected to the concept of globalization and climate changes. The 
ongoing emergency demands a politically correct and holistic switching 
from globalization to global health, as highlighted even before the 
spread of SARS-CoV 2 [2]. Sustainable nutrition encompasses the safe 
supply of adequate food and nutrients to everyone but at the same time 
involves the preservation of the environment, biodiversity and local 
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resources [3]. 
1.1. Personalized and precision nutrition 
Since the 2000s advancements in genotyping technology, coupled 
with the reduction in the costs of genome sequencing and the more 
recent advent of digital technologies in healthcare, did initiate a third 
revolution in medicine. These technologies are creating unprecedented 
opportunities for primary disease prevention, diagnosis and treatment 
and for secondary disease monitoring on a personalized basis, both 
within the health system and beyond. Given the potential for effective 
public health preventive efforts in postponing the onset of disabilities 
and reducing healthcare costs, the expectation is that the current ‘one 
size fits all’ approach in primary prevention takes advantage of the new 
technologies in healthcare in order to be more targeted at those in need. 
In the context of nutrition science, modern views on food have led to 
a substantial shift in nutrition research and practice known as precision 
nutrition, which endows the potential to offer multidimensional and 
dynamic recommendations on the quality and quantity of food [4]. Like 
precision medicine, precision nutrition aims to understand the effects on 
health of the complex interplay of genome, microbiome, anti-
biotic/probiotic use, metabolome, food environment but also of eco-
nomic, social and behavioral variables, thus allowing a targeted and 
personalized dietary management with the goal to prevent and treat 
nutrition-related disorders. Precision nutrition might therefore be 
considered a subset of precision medicine and an important additional 
factor in the primary and secondary prevention of such 
non-communicable diseases as diabetes, neurodegenerative diseases, 
atherothrombotic cardiovascular diseases and cancer, that all represent 
a huge global burden for healthcare systems and individuals. All these 
diseases have common denominators, i.e., a chronic inflammatory state 
and metabolic derangement, which may be triggered by a genetic pre-
disposition to an impaired physiological response to environmental in-
sults. In this context, the use of polygenic scores for common disease risk 
assessment [5] represents an important area of progress for public health 
[6], because if preventive interventions are targeted mainly to those 
individuals who are going to get an illness, the ensuing focused approach 
is obviously more efficacious and cost-effective (and also likely more 
cost-saving) than a traditional one-size-fits-all approach [7]. In the 
foreseeable future, information from the DNA sequence of individuals is 
likely to become part of their electronic medical records and thus used to 
inform their healthcare strategies throughout the whole life course. 
The use of artificial intelligence represents an additional tool 
potentially able to improve precision and prediction accuracy in various 
clinical settings. The approach based upon the artificial neural network 
should help to integrate at an individual level the main biological in-
dicators, i.e., basal energy expenditure, metabolic flexibility, micro-
biome (at the interface between food intake and nutrient absorption) 
and also metabolome, that involves the quantitative analysis of 
byproducts of cellular activity, in turn derived from the metabolic 
pathways of living systems [4]. As an end by-product, smart phone apps 
might help to translate nutritional recommendations into individual 
lifestyles [8]. However, reliability and feasibility of personalized nutri-
tion are still challenged by issues requiring further investigation. For 
instance, manipulation of the microbiome is challenged by the varied 
ethnicities and geographic localizations, emphasizing once more the 
close connection between earth and individual health [9] and also 
indicating that the refinement of the related interventions requires data 
input from different and well characterized ethnic groups [10]. Unfor-
tunately, the evidence stemming from evaluations on the financial sus-
tainability of such personalized interventions currently limits their 
implementation even in high income countries, further stressing the 
negative impact played by social inequalities. Last but not least, even 
well-defined and well-planned interventions require a high degree of 
adherence, that depends on the psychological features of each individual 
[11]. 
With this background and gaps of knowledge, current evidence on 
the effectiveness of personalized nutrition is limited to adult populations 
but is still unknown how children would respond. New efforts from the 
pediatric communities are warranted to investigate the impact of this 
approach in children, in a way comprehensive of all the aspects con-
cerning the nutritional status, metabolism and nutritional requirements. 
Owing to the large number of variables and their implications, emphasis 
should be given and more efforts directed towards the implementation 
of highly effective nutrition-specific and nutrition-sensitive in-
terventions able to support, starting from the earliest ages of life, a 
healthy development at an individual level, that will also impinge upon 
the levels and quality of health in adulthood. 
Consistent with the present and prospective applications of person-
alized nutrition, social interventions aimed to improve socioeconomical 
conditions at a population level represent a key goal in order to reach an 
acceptable degree of effectiveness regarding primary prevention and 
treatment [12]. The evidence stemming from randomized clinical trials 
is essential but cannot be the only approach. Interventions on dietary 
habits also demand to consider food security, cost and environmental 
sustainability and thus imply a broad concept of wellbeing that en-
compasses but goes beyond the effects on health. Nutrition and food 
warrant research programs where medical science (nutrition and 
health), psychology (how we behave), economy (how resources are used 
and their impact on wellbeing) and sociology (how social determinants 
shape human behavior) interact in the frame of an integrated approach. 
1.2. The issue of saturated fats: time to change the guidelines? 
In adults, the number one global cause of death are atherothrombotic 
cardiovascular disease. Historically, the so-called lipid hypothesis 
focused on the detrimental role of saturated fats per se in enhancing the 
risk of cardiovascular disease. Accordingly, authoritative institutional 
bodies in the USA as well as in Europe still maintain dietary recom-
mendations focused on saturated fatty acids and suggest to keep their 
intake as low as possible [13]. On the other hand, the current assessment 
of disease risk associated with dietary fat consumption emphasizes the 
confounding nature of the macronutrients that replace saturated fats in 
diets (for instance carbohydrates, including their various forms and 
sources) and give broader recognition to the impact played by the food 
matrix per se and the by whole pattern of food composition as the most 
productive approach towards an overall healthy diet [14]. For sake of an 
example, low density lipoproteins (LDL) are made of subclasses of par-
ticles with differing cholesterol content and atherogenic properties [15]. 
Dietary carbohydrates and saturated fats have divergent effects on LDL 
subclasses, so that a high intake of carbohydrates increases small LDL 
particles, whereas a high intake of saturated fats does increase larger 
particles [16]. Small and very small LDL particles are characterized by 
defective plasma clearance, larger entry and retention into the arterial 
wall as well as faster oxidation [15]. Current evidence-based effects of 
SFA on health depend on the interaction of the effects stemming from 
naturally occurring food components but also of those stemming from 
the unhealthy components introduced during food processing. A com-
plex food matrix with a high SFA content but also with other nutrients 
and non-nutritional components (e.g. proteins, micronutrients, phos-
pholipids, probiotics) – as is for instance the case for soft and hard cheese 
but also for fermented diary products such as yoghurt and kefir – is 
associated with no increased risk of cardiovascular disease and diabetes 
[17]. Thus, cogent dietary recommendations should rather emphasize 
strategies based upon the whole food matrix, to be conveyed to the 
community as understandable, consistent and robust recommendations 
on healthy dietary patterns. 
Several systematic reviews and meta-analyses recently addressed the 
saturated fat controversy, i.e., whether or not saturated fat intake is a 
risk factor for atherothrombotic cardiovascular diseases. The totality of 
evidence, i.e. meta-analyses or systematic reviews of both observational 
studies and randomized clinical trials, fails to demonstrate harmful 
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effects of SFA on excessive body weight, metabolic syndrome, type 2 
diabetes or cardiovascular disease when compared with diets rich in 
carbohydrates designed to replace fats [18]. Accordingly, dairy products 
such as yoghurt and cheese do not exert detrimental effects on serum 
lipids on the basis of their high content in saturated fat [19], and butter 
consumption shows relatively small or neutral associations with mor-
tality and cardiovascular disease and even an inverse association with 
the incidence of diabetes [20]. The beneficial effects of yoghurt and 
cheese on diabetes and cardiovascular risk are likely related to the whole 
food matrix and associated nutrients (i.e. protein, calcium, short-chain 
fatty acids (SFA, i.e., acetic, propionic and butyric acid) but also to 
peptides and complex phospholipids that are components of the func-
tionally effective membrane-associated receptors. Therefore, while the 
low-fat versions of these foods might be helpful for overweight and 
insulin-resistant obese individuals, the full fat versions can be safely 
used by patients with type 2 diabetes. Interest on the dietary role and 
metabolic effects of SFA has been recently revamped by epidemiological 
observations leading to a fresh approach to health and well-being [21]. 
Furthermore, palm oil rich in palmitic acid was shown to favorably in-
crease HDL cholesterol with no changes in the total cholesterol/HDL 
ratio [22]. Continuous updating of the evidence stemming from existing 
reviews, as well as from new systematic narrative reviews are warranted 
to tackle areas where the role of saturated fat remains unclear. Yet, the 
totality of current evidence shows that cutting down the intake of 
saturated fat should be avoided and that dietary recommendations 
should be rather focused on the choice of the type of food. Future 
research should also include objective cost-benefit analyses capable to 
disentangle the role of saturated fat in the context of broad dietary 
recommendations. 
1.3. Focus on palmitic acid: from fetal life through adulthood 
Pertaining to saturated fatty acids, in recent years there has been a 
heated debate on palmitic acid regarding its biological role per se [23] 
but also pertaining to the sustainability of its major plant sources as 
palm oil. Palmitic acid (16:0) is a saturated fatty acid present in the diet 
but also endogenously synthesized. Among fatty acids 16:0 has special 
structural and functional roles during the very early stages of life, for its 
role in the developing fetus but also for being the main dietary 
component for energy and storage purposes during lactation [24]. 
During the fetal life 16:0 is a crucial component of the surfactant of 
pulmonary alveoli, i.e., a surface-active lipoprotein complex (phospho-
lipoprotein) produced by type II alveolar cells [25]. Proteins and lipids 
that make up the surfactant have both hydrophilic and hydrophobic 
regions. By adsorbing onto the air-water interface of the alveoli, with 
hydrophilic head groups facing water and the hydrophobic tails facing 
air, the main lipid component of the surfactant dipalmitoylphosphati-
dylcholine (DPPC) – a phospholipid consisting of two C16 palmitic acid 
groups attached to a phosphatidylcholine head-group – reduces surface 
tension and facilitates the act of breathing, thus preventing alveolar 
collapse. The chemically synthesized pulmonary surfactant is included 
in the WHO Model List of Essential Medicines, the most important drugs 
needed also in basic healthcare systems. 
At birth, the term infant is 13–15% of body fat with 45–50% of 16:0, 
much of which is derived from endogenous synthesis in the fetus. After 
birth, the infant accumulates adipose tissue at high rates, reaching the 
proportion of 25% of body weight as fat by 4–5 months of age [24]. Over 
this time, human milk provides 10% of the dietary energy as 16:0 in the 
frame of peculiar triglycerides characterized by 16:0 complexed in the 
center of the triglyceride molecule [26]. This composition allows better 
energy absorption while preventing the precipitation of calcium soaps 
with lipids, thus reinforcing the concept of human milk as a full and 
complete biological system. In addition, palmitic acid at the sn-2 posi-
tion of triacylglycerol backbone modulates N-acylethanolamine levels in 
rat tissues, that possibly explains its effects on lipid and energy meta-
bolism [27]. Furthermore, feeding rats with human and donkey milk, 
both characterized by a relative high level of triacylglycerol enriched in 
palmitic acid at the sn-2 position, favourably modified inflammation 
markers as well as glucose and lipid metabolism due to a modulation of 
mitochondrial function and efficiency [28]. Assuming that fetal fatty 
acid synthesis and the peculiar delivery of 16:0 in the human milk did 
help during the evolution to afford survival advantage to the neonate, it 
is a timely question whether or not 16:0, i.e., is a non-essential dietary 
component efficiently synthesized via endogenous reactions, represents 
an essential component among the exogenous nutrients supplied in the 
intrauterine phase and the early postnatal period. Optimal ranges of 
supply and intake need to be established, considering the possibility that 
during the early stages of life both deficiency and excess may have 
detrimental effects that to impinge on the overall health of the indi-
vidual in later life stages. 
In adults palmitic acid represents approximately 20–30% of the total 
fatty acids in our body and therefore a man weighing 70 kg is made on 
average of approximately 3.5 kg of palmitic acid [29]. Its daily food 
intake is approximately 20 g and represents around 8% of the total 
calories [29]. Although often considered to have adverse effects on non 
–communicable diseases, 16:0 is an essential component of the mem-
brane secretory and transport lipids, because it plays crucial roles on 
protein palmitoylation and formation of signal molecules and receptors 
[23]. Specific metabolic conditions related to overweight, visceral 
obesity and a sedentary lifestyle are often associated to metabolic 
inflexibility when the inability to efficiently store and use energy sub-
strate may favor a dysregulated de novo lipogenesis and increased 
endogenous production of palmitic acid [30]. The latter is often asso-
ciated with an excess of ectopic fat deposition coupled with a lower 
capability of physical activity, so that a sum of unfavorable conditions 
takes place stemming from a lower degree of glucose tolerance and in-
sulin sensitivity, that are widely recognized to be key mechanisms for 
the onset of the metabolic syndrome that predisposes to cardiovascular 
diseases. 
Therefore, dysregulated de novo lipogenesis and dietary SAFA/PUFA 
imbalance may both lead to the metabolic syndrome, metabolic inflex-
ibility and a dysbiotic microbiome through distinct pathways (Fig. 1). 
Increased endogenous production of palmitic acid may rise inflamma-
tion susceptibility through activation of TLR4 [31] and enhance insulin 
resistance by ceramide formation [32]. On the other hand, reducing 
PUFA intake, particularly n-3 highly PUFA, may favor dyslipidemia, 
hypertension and insulin resistance [33]. Thus, unbalanced body 
composition and reduced physical fitness might be either cause or 
consequence of de novo lipogenesis and unbalanced SAFA/PUFA intake. 
Since these two dysmetabolic conditions often occur concurrently, 
increased tissue palmitic acid and related deleterious consequences from 
a dysregulated de novo lipogenesis may be wrongly ascribed to the di-
etary intake of palmitic acid. The invidual capability to manage the 
glucose/insulin axis may be considered a major factor in the frame of the 
concept of energy balance and storage. Indeed, patients with overweight 
and obesity show considerable interindividual variability in the weight 
loss response to dietary treatments depending on their insulin resistance 
and glucose intolerance. In contrast, individual patients are often 
assumed by clinicians to respond similarly to various diet and exercise 
prescriptions. Nevertheless, variation in baseline glycemic control in 
people with overweight and obesity but without type 2 diabetes, such as 
the presence of normoglycemia or prediabetes, might lead to variable 
success in weight loss and metabolic responses to dietary treatments 
[34]. Recent data particularly suggest that a high content of dietary fiber 
is beneficial for people with prediabetes, due perhaps to fermentation by 
the microbes and production of short chain fatty acids that favorably 
influence the individual glucose/insulin axis [35] 
2. Conclusions 
The perspective of sustainable nutrition offers a novel and holistic 
approach to the millenarian fight against malnutrition with its double 
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edge sword, i.e., inadequate versus excess energy/nutrient intake. This 
issue was endorsed by Pope Francis in the message that on October 16, 
2020 he addressed on the occasion of the World Food Day to Qu Dongyu, 
director general of the Food and Agriculture Organization (FAO). Due to 
the ongoing rapid global transition, an increasing proportion of in-
dividuals are exposed to different patterns of inadequate nutrition dur-
ing their life course and face the double burden of malnutrition and 
overweight as victims of improper dietary habits [36]. In this frame, 
sustainable nutrition may be able to deliver at a global level a positive 
message in terms of support to health and well-being for the populations 
of the planet. New positive messages on saturated fatty acids may offer 
an alternative as a widely affordable and sustainable source of energy, 
cheap and tasty. However, interventions are necessary to promote the 
capability to adapt messages in order to match individual needs to 
available resources, with the awareness that doing the best for the planet 
may also be the best in terms of personal health and disease prevention. 
Thus, food diversity represents the perfect link between sustainable and 
personalized nutrition (Fig. 2), in the context of the respect of 
geographical and ethnic variabilities and it should emphasize once more 
as a healthy way towards more emphasis on the complex human-mother 
earth diade. Lastly, a warning must be clearly expressed concerning the 
differences in promoting global health versus dietary interventions in 
secondary prevention programs, when overt symptoms have already 
materialized leading to the diagnosis of significant disorders. In these 
conditions, the holistic/global approach of the EAT commission (3) 
should be considered apart, and the considerations already mentioned 
for the glucose/insulin axis (34) taken as prescriptive of an individual-
ized approach. 
Fig. 1. Pathophysiological consequences of dysregulated de novo lipogenesis and unbalanced dietary PUFA/SFA ratio converge to contribute to the metabolic 
syndrome, metabolic inflexibility and dysbiotic microbiome, which in the long term result into body composition imbalance and lower capability of physical activity, 
starting a vicious circle. 
Fig. 2. Food diversity represents a valid strategy for both sustainable and 
personalized nutrition. Furthermore, it may contribute to maintain the ho-
meostatic control of body composition and thereby healthy growing and aging 
through the prevision of guaranteeing a balanced nutrient intake, microbiome 
diversity, metabolic flexibility and physical fitness. 
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